Patent Number: 7,709,233

Title: Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer

Abstract: The methods of the invention detect epidermal growth factor RNA, epidermal growth factor receptor RNA, her-2/neu RNA, c-myc RNA, heterogeneous nuclear ribonucleoprotein A2/B1 RNA or any combination thereof in blood plasma, serum, and other bodily fluids. The inventive methods are useful for detection, diagnosis, monitoring, treatment, or evaluation of neoplastic disease.

Inventors: Kopreski; Michael S. (Long Valley, NJ)

Assignee: OncoMEDx, Inc.

International Classification: C12P 19/34 (20060101); C07H 21/00 (20060101); C12Q 1/68 (20060101); C07H 21/02 (20060101); C07H 21/04 (20060101)

Expiration Date: 5/04/12018